Active ingredientTroglitazoneCat. No. P-T225-001CAS 97322-87-7Family · Pharmaceutical analytical standards
Troglitazone
An antidiabetic of the glitazone (thiazolidinedione) class developed in Japan, which improves insulin sensitivity by activating the PPAR-gamma receptor: approved in the United States in 1997, it remained on the market until 2000. This family brings together the active ingredient, metabolites, labelled standards and other impurities.
Did you know?Its structure contains a piece of vitamin E: a chromane ring like that of alpha-tocopherol, attached to the thiazolidinedione core typical of the glitazones.
Go to the active ingredient →Active ingredientTroglitazoneCat. No. P-T225-001CAS 97322-87-7
Active ingredientTroglitazone SulfateCat. No. P-T225-002
MetaboliteTroglitazone GlucuronideCat. No. P-T225-003CAS 127040-01-1
Isotopically labelledTroglitazone-d4Cat. No. P-T225-004CAS 2749370-85-0
Isotopically labelledTroglitazone-d4 GlucuronideCat. No. P-T225-005
Isotopically labelledTroglitazone-d4 QuinoneCat. No. P-T225-006
ImpurityTroglitazone QuinoneCat. No. P-T225-008No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.